Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series
Treatment options in advanced Parkinson’s disease (PD) include subcutaneous apomorphine, pallidal or subthalamic nucleus Deep Brain Stimulation (DBS), or levodopa/carbidopa intestinal gel (LCIG/Duodopa). In this study, we describe the outcome of 12 PD patients with PD related complications started o...
Saved in:
Main Authors: | T. Foltynie, C. Magee, C. James, G. J. M. Webster, A. J. Lees, P. Limousin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2013/362908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Anxiety on Quality of Life in Parkinson's Disease
by: Kristine K. Hanna, et al.
Published: (2012-01-01) -
Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort
by: Jade E. Kenna, et al.
Published: (2022-01-01) -
The Neurobehavioural Abnormalities in Parkinson’s Disease and their Relationship to Psychomotor Retardation and Obsessional Compulsive Disorders
by: A. J. Lees
Published: (1989-01-01) -
Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson’s Disease
by: Márton Kovács, et al.
Published: (2016-01-01) -
Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson’s Disease Patients
by: D. Rada, et al.
Published: (2016-01-01)